Markowski Investments’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.96K Hold
105
– – ﹤0.01% 591
2026
Q2
$2.1K Buy
+105
New +$1.86K ﹤0.01% 540

Other funds holding HQL

Markowski Investments's HQL Position: Q3 2026 in Review

Markowski Investments held its abrdn Life Sciences Investors (HQL) position steady in Q3 2026 at 105 shares worth $1.96K. The position accounts for ﹤0.01% of the portfolio, ranked #591.

Markowski Investments first reported a position in HQL in Q2 2026 and has held it in 2 quarters since. The position peaked at $2.1K in Q2 2026. 83 funds tracked by Wall St. Rank hold HQL as of Q3 2026.

  • Markowski Investments held 105 shares of abrdn Life Sciences Investors worth $1.96K as of Q3 2026.
  • Markowski Investments left its abrdn Life Sciences Investors share count unchanged in Q3 2026.
  • abrdn Life Sciences Investors made up ﹤0.01% of Markowski Investments's portfolio in Q3 2026, its #591 holding.
  • Markowski Investments first reported a position in abrdn Life Sciences Investors in Q2 2026 and has held it in 2 quarters since.
  • Markowski Investments's abrdn Life Sciences Investors position peaked at $2.1K in Q2 2026.
  • 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2026.

Based on Markowski Investments's 13F filing for Q3 2026, filed 30 Oct 2026.